Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,845 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exploratory field study on the effects of porcine circovirus 2 (PCV-2) sow vaccination at different physiological stages mimicking blanket vaccination.
Pleguezuelos P, Sibila M, Cuadrado R, López-Jiménez R, Pérez D, Huerta E, Llorens AM, Núñez JI, Segalés J, López-Soria S. Pleguezuelos P, et al. Among authors: perez d. Porcine Health Manag. 2021 Apr 26;7(1):35. doi: 10.1186/s40813-021-00213-2. Porcine Health Manag. 2021. PMID: 33902747 Free PMC article.
Comparison of Mycoplasma hyopneumoniae and porcine circovirus 2 commercial vaccines efficacy when applied separate or combined under experimental conditions.
Sibila M, Guevara G, Cuadrado R, Pleguezuelos P, Pérez D, Pérez de Rozas A, Huerta E, Llorens A, Valero O, Pérez M, López C, Krejci R, Segalés J. Sibila M, et al. Among authors: perez m, perez de rozas a, perez d. Porcine Health Manag. 2020 May 4;6:11. doi: 10.1186/s40813-020-00148-0. eCollection 2020. Porcine Health Manag. 2020. PMID: 32391165 Free PMC article.
Efficacy Studies of a Trivalent Vaccine Containing PCV-2a, PCV-2b Genotypes and Mycoplasma hyopneumoniae When Administered at 3 Days of Age and 3 Weeks Later against Porcine Circovirus 2 (PCV-2) Infection.
Pleguezuelos P, Sibila M, Cuadrado-Matías R, López-Jiménez R, Pérez D, Huerta E, Pérez M, Correa-Fiz F, Mancera-Gracia JC, Taylor LP, Borowski S, Saunders G, Segalés J, López-Soria S, Balasch M. Pleguezuelos P, et al. Among authors: perez m, perez d. Vaccines (Basel). 2022 Aug 1;10(8):1234. doi: 10.3390/vaccines10081234. Vaccines (Basel). 2022. PMID: 36016122 Free PMC article.
Efficacy Studies against PCV-2 of a New Trivalent Vaccine including PCV-2a and PCV-2b Genotypes and Mycoplasma hyopneumoniae When Administered at 3 Weeks of Age.
Pleguezuelos P, Sibila M, Ramírez C, López-Jiménez R, Pérez D, Huerta E, Llorens AM, Pérez M, Correa-Fiz F, Mancera Gracia JC, Taylor LP, Smith J, Bandrick M, Borowski S, Saunders G, Segalés J, López-Soria S, Fort M, Balasch M. Pleguezuelos P, et al. Among authors: perez m, perez d. Vaccines (Basel). 2022 Dec 9;10(12):2108. doi: 10.3390/vaccines10122108. Vaccines (Basel). 2022. PMID: 36560518 Free PMC article.
1,845 results